Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Insight Molecular Diagnostics (IMDX) Other Gross PP&E Adjustments (2020 - 2025)

Insight Molecular Diagnostics' Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$12.9 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 15.02% year-over-year to -$12.9 million; the TTM value through Sep 2025 reached -$12.9 million, down 15.02%, while the annual FY2024 figure was -$11.5 million, 142.3% down from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$12.9 million at Insight Molecular Diagnostics, down from -$12.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $4.7 million in Q2 2021 and bottomed at -$13.7 million in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$4.7 million (2023), against an average of -$5.5 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 441.68% in 2021 before it crashed 2051.57% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$638000.0 in 2021, then plummeted by 2051.57% to -$13.7 million in 2022, then skyrocketed by 65.54% to -$4.7 million in 2023, then tumbled by 142.3% to -$11.5 million in 2024, then dropped by 12.64% to -$12.9 million in 2025.
  • Per Business Quant, the three most recent readings for IMDX's Other Gross PP&E Adjustments are -$12.9 million (Q3 2025), -$12.6 million (Q2 2025), and -$12.7 million (Q1 2025).